Market Misconduct Tribunal sanctions Augustine Cheong for insider dealing in Titan shares


The Market Misconduct Tribunal (MMT) has found that a former senior executive of an affiliate of Titan Petrochemicals Group Limited (Titan), Mr Augustine Cheong Kai Tjieh, and his mother, Ms Gan Ser Soon, engaged in insider dealing in the shares of Titan in January 2012.

Cheong and Gan were found to have sold their Titan shares while they knew inside information that Titan faced extremely difficult financial problems related to the likelihood of defaults by Titan and/or its subsidiaries on outstanding bank loans and certain fixed rate senior notes. Cheong gave Gan the inside information.

The MMT has ordered Cheong and Gan:

  • to disgorge the losses they avoided totaling $2,425,174 by selling Titan shares;
  • not to deal, directly or indirectly in Hong Kong, in SFC regulated financial products for two years and one year, respectively;
  • not to insider deal again; and
  • to pay the SFC’s legal and investigation costs and the costs of the MMT.

The MMT took into account the admissions in a Statement of Agreed and Admitted Facts signed by Cheong and Gan, and considered that the orders the SFC proposed and agreed by them were proportional, sensible and acceptable in the circumstances.

The SFC has also instituted parallel proceedings in the Court of First Instance under section 213 of the Securities and Futures Ordinance against the two for their alleged insider dealing in Titan shares. In these proceedings, the SFC seeks an order to restore relevant counterparties of Cheong and Gan’s sales of Titan shares to the positions they were in before they bought those shares from Cheong and Gan.

Related News

arrow

Market Misconduct Tribunal sanctions Augustine Cheong for insider dealing in Titan shares

2

Send this to a friend

Fill out the form below for more information
for lising in LeapRate's Forex Yellow Pages

Please enter the company name, email address to reach you and phone # (optional):

Please fill out the message field to the right for any questions or special inquiry: